# New TB risk data raises the bar on your GLP-1 sourcing - facts

Canonical page: https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing
Type: Lab article

## TL;DR

New observational data links GLP-1 receptor agonists to fewer tuberculosis diagnoses in type 2 diabetes. Why sourcing and endotoxin control matter in the lab.

## Facts Index

| Fact ID | Category | Entity | Attribute | Value | Source | Evidence |
|---|---|---|---|---|---|---|
| new-tb-risk-data-raises-bar-glp-1-sourcing:title | identity | New TB risk data raises the bar on your GLP-1 sourcing | title | New TB risk data raises the bar on your GLP-1 sourcing | Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing) | https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing |
| new-tb-risk-data-raises-bar-glp-1-sourcing:published | identity | New TB risk data raises the bar on your GLP-1 sourcing | published | 2026-08-22 | Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing) | https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing |
| new-tb-risk-data-raises-bar-glp-1-sourcing:author | identity | New TB risk data raises the bar on your GLP-1 sourcing | author | PreppinPeppers Editorial Team | Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing) | https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing |
| new-tb-risk-data-raises-bar-glp-1-sourcing:topics | identity | New TB risk data raises the bar on your GLP-1 sourcing | topics | News, peptide news, research news | Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing) | https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing |
| new-tb-risk-data-raises-bar-glp-1-sourcing:summary | content | New TB risk data raises the bar on your GLP-1 sourcing | summary | New observational data links GLP-1 receptor agonists to fewer tuberculosis diagnoses in type 2 diabetes. Why sourcing and endotoxin control matter in the lab. | Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing) | https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing |
| new-tb-risk-data-raises-bar-glp-1-sourcing:section-1 | content | New TB risk data raises the bar on your GLP-1 sourcing | section | What they are | Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing) | https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing |
| new-tb-risk-data-raises-bar-glp-1-sourcing:section-2 | content | New TB risk data raises the bar on your GLP-1 sourcing | section | What the finding actually covers | Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing) | https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing |
| new-tb-risk-data-raises-bar-glp-1-sourcing:section-3 | content | New TB risk data raises the bar on your GLP-1 sourcing | section | Not every GLP-1 compound is the same molecule | Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing) | https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing |
| new-tb-risk-data-raises-bar-glp-1-sourcing:section-4 | content | New TB risk data raises the bar on your GLP-1 sourcing | section | Where the research community gets this wrong | Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing) | https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing |
| new-tb-risk-data-raises-bar-glp-1-sourcing:source-bioengineer-org | source | New TB risk data raises the bar on your GLP-1 sourcing | cites | this coverage at Bioengineer.org → - bioengineer.org | Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing) | https://bioengineer.org/glp-1-drugs-and-tuberculosis-risk-in-people-with-type-2-diabetes/ |
| new-tb-risk-data-raises-bar-glp-1-sourcing:source-pmc-ncbi-nlm-nih-gov | source | New TB risk data raises the bar on your GLP-1 sourcing | cites | Liao et al., Nat Commun 2026: Glucagon-like Peptide-1 Receptor Agonists and Risk of Tuberculosis in Type 2 Diabetes - pmc.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing) | https://pmc.ncbi.nlm.nih.gov/articles/PMC13594082/ |
| new-tb-risk-data-raises-bar-glp-1-sourcing:product-gansulin-metal-peptide-pen | products | New TB risk data raises the bar on your GLP-1 sourcing | references product | Gansulin Pen · Reusable Click-Dial, 3 ml (1-60 Units) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing) | https://www.preppinpeppers.com/products/gansulin-metal-peptide-pen |
| new-tb-risk-data-raises-bar-glp-1-sourcing:product-gansulin-3ml-cartridge | products | New TB risk data raises the bar on your GLP-1 sourcing | references product | Gansulin-Compatible 3 ml Glass Cartridge for Pens (10-Pack) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/new-tb-risk-data-raises-bar-glp-1-sourcing) | https://www.preppinpeppers.com/products/gansulin-3ml-cartridge |

## FAQ

### Do GLP-1 receptor agonists lower tuberculosis risk?

An observational analysis found fewer TB diagnoses among people with type 2 diabetes using GLP-1 receptor agonists versus other diabetes drugs, but this is an association, not proof the peptide directly blocks infection.

### Why does diabetes raise tuberculosis risk?

Long-term high blood sugar weakens macrophages, the immune cells that normally surround and destroy the TB bacterium, making infection more likely to take hold and progress.

### Are semaglutide, tirzepatide, and retatrutide the same class of compound?

No. Semaglutide targets only the GLP-1 receptor, tirzepatide targets GLP-1 and GIP receptors, and retatrutide targets GLP-1, GIP, and glucagon receptors, so effects aren't interchangeable in research.

---
Built from PreppinPeppers store data and verified sources only. Same content for every visitor. Research and educational use only, not for human or veterinary use.